Bankruptcy and the Regeneron Acquisition
When 23andMe filed for bankruptcy, many users wondered what would happen to their stored data. Financial instability often results in company assets being sold off.
User data is often considered a valuable asset, especially when it includes sensitive health and genetic profiles. With Regeneron’s planned acquisition, many customers have expressed concern over potential misuse or lack of consent.
Although Regeneron stated they will respect current privacy policies, nothing prevents future changes. Once new ownership takes over, user agreements may evolve. Customers might be opted into data-sharing terms they would not have accepted before.
Bankruptcy also creates legal gray areas. Previous promises around data privacy might be restructured or challenged during asset transfers. Deleting your data may be the only way to ensure control.
